You have 9 free searches left this month | for more free features.

Boston keratoprosthesis type 1

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Corneal Transplantation, Glaucoma Trial in Montreal (Boston keratoprosthesis type 1, Glaucoma drainage device)

Recruiting
  • Corneal Transplantation
  • Glaucoma
  • Boston keratoprosthesis type 1
  • Glaucoma drainage device
  • Montreal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal (CHUM)
Nov 16, 2022

Corneal Transplantation, Glaucoma and Ocular Hypertension, Postoperative Complications Trial in Montréal (Boston

Recruiting
  • Corneal Transplantation
  • +4 more
  • Boston keratoprosthesis type 1 and anterior hyaloid membrane peeling assisted by endoscopy
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal (CHUM)
Jul 4, 2022

Corneal Blindness, Boston Keratoprosthesis Type I Candidate Trial in Montréal (Boston KPro type I - fresh graft, Boston KPro

Completed
  • Corneal Blindness
  • Boston Keratoprosthesis Type I Candidate
  • Boston KPro type I - fresh graft
  • Boston KPro type I surgery - frozen graft
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Jan 26, 2021

Glaucoma, Eye Diseases, Cornea Disease Trial in Montreal (Transscleral cyclphophotocoagulation using the Micropulse system (

Recruiting
  • Glaucoma
  • +2 more
  • Transscleral cyclphophotocoagulation using the Micropulse system ( IRIDEX IQ810 Laser systems, Mountain View, CA).
  • G-Probe transscleral cyclphophotocoagulation (Iris Medical Instruments, Montain View, CA)
  • Montreal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal (CHUM)
Jan 23, 2023

Glaucoma, Corneal Transplantation, Inflammation Trial in Montréal (Sampling of tears, Sampling of aqueous humor)

Recruiting
  • Glaucoma
  • +2 more
  • Sampling of tears
  • Sampling of aqueous humor
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal (CHUM)
Jul 4, 2022

Neurofibromatosis 1 Trial in Boston (Kybella, Asclera)

Recruiting
  • Neurofibromatosis 1
  • Boston, Massachusetts
    Wellman Center for Photomedicine
Nov 1, 2023

Neurofibromatosis 1 Trial in Boston (Deoxycholic Acid, Polidocanol, 1064nm Nd:YAG laser)

Not yet recruiting
  • Neurofibromatosis 1
  • Deoxycholic Acid
  • +3 more
  • Boston, Massachusetts
    Wellman Center for Photomedicine
Nov 13, 2023

Type 1 Diabetes, Type 2 Diabetes Trial in Boston (Diabetes Collaborative Care Model for Young Adults, Usual Care Model)

Active, not recruiting
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Diabetes Collaborative Care Model for Young Adults
  • Usual Care Model
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

Type 1 Diabetes Trial in Aurora, Boston, Charlottesville (t:slim X2 insulin pump with Control-IQ technology 2.0)

Recruiting
  • Type 1 Diabetes
  • t:slim X2 insulin pump with Control-IQ technology 2.0
  • Aurora, Colorado
  • +3 more
Jan 26, 2023

Diabetes, Type 1 Diabetes Trial in Boston, Bronx (Unified protocol for cognitive behavioral therapy (UP-CBT), Continuous Glucose

Not yet recruiting
  • Diabetes
  • Type 1 Diabetes
  • Unified protocol for cognitive behavioral therapy (UP-CBT)
  • Continuous Glucose Monitoring (CGM)
  • Boston, Massachusetts
  • +1 more
Feb 16, 2023

NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Active, not recruiting
  • Nonalcoholic Fatty Liver
  • +4 more
  • Transient Elastography
  • Boston, Massachusetts
    Joslin Diabetes Center
Sep 16, 2022

Cutaneous Neurofibroma Trial in Boston (Kybella, 980nm laser, 755nm Alexandrite Laser)

Recruiting
  • Cutaneous Neurofibroma
  • Boston, Massachusetts
    Wellman Center for Photomedicine, Massachusetts General Hospital
Aug 10, 2022

Type1diabetes Trial in Boston (very low carbohydrate diet, standard carbohydrate diet)

Recruiting
  • Type1diabetes
  • very low carbohydrate diet
  • standard carbohydrate diet
  • Boston, Massachusetts
    Boston Children's Hospital
Mar 4, 2022

Diabetic Nephropathies Trial in Boston, Ann Arbor (Fenofibrate, Placebo)

Recruiting
  • Diabetic Nephropathies
  • Boston, Massachusetts
  • +1 more
Aug 15, 2022

Type 1 Diabetes Trial in Palo Alto, Boston (Psychoeducation to reduce diabetes distress and improve glycemic outcomes)

Recruiting
  • Type 1 Diabetes
  • Psychoeducation to reduce diabetes distress and improve glycemic outcomes
  • Palo Alto, California
  • +1 more
Jul 27, 2022

Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy

Recruiting
  • Myotonic Dystrophy Type 1
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 4, 2023

    Type 1 Diabetes, Eating Disorders Trial in Netherlands, Norway, United States (Diabetes Body Project, Educational Group)

    Not yet recruiting
    • Type 1 Diabetes
    • Eating Disorders
    • Diabetes Body Project
    • Educational Group
    • Stanford, California
    • +3 more
    Jul 10, 2022

    Type 1 Diabetes Trial in Boston (Humalog, Novolog, BC222 insulin lispro)

    Terminated
    • Type 1 Diabetes Mellitus
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 10, 2022

    Comparative Effectiveness of Empagliflozin in the US

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • Boston, Massachusetts
      Bringham Women Hospital
    Jan 9, 2023

    LabPatch Glucose Sensing System in Insulin-treated Diabetes

    Recruiting
    • Type 1 Diabetes Mellitus
    • Type 2 Diabetes Mellitus
    • 2nd Gen LabPatch Glucose Sensing System
    • Boston, Massachusetts
      Joslin Diabetes Center
    Feb 22, 2023

    Diabetes, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia Trial in Canada, United States (VX-880)

    Recruiting
    • Diabetes Mellitus, Type 1
    • +2 more
    • VX-880
    • Duarte, California
    • +10 more
    Aug 8, 2022

    Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

    Recruiting
    • Primary Hyperoxaluria Type 1
      • Phoenix, Arizona
      • +10 more
      Aug 11, 2022

      Type 1 Diabetes Trial in United States (t:slim X2 insulin pump with Control-IQ technology 1.5)

      Recruiting
      • Type 1 Diabetes
      • t:slim X2 insulin pump with Control-IQ technology 1.5
      • Orange, California
      • +13 more
      Jan 18, 2023

      Breath and Sweat to Identify Indicators of Hypoglycemia

      Completed
      • Type 1 Diabetes Mellitus
        • Boston, Massachusetts
          Massachusetts General Hospital (MGH) Diabetes Research Center
        Mar 23, 2022

        Idiopathic Pulmonary Fibrosis Trial in Boston (PLN-74809, Placebo)

        Recruiting
        • Idiopathic Pulmonary Fibrosis
        • Boston, Massachusetts
          Massachusetts General Hospital
        Nov 14, 2022